NVO Misses Q3 Earnings & Revenue Estimates, Updates 2024 View

Novo Nordisk A/S (NVO) reported third-quarter 2024 earnings of 90 cents per American Depositary Receipt (ADR), which marginally missed the Zacks Consensus Estimate of 91 cents. The company had reported earnings of 73 cents per ADR in the year-ago quarter.Revenues of $10.5 billion increased 21% in Danish kroner (DKK) and 23% at constant exchange rate (CER) in the reported quarter. However, total revenues also missed the Zacks Consensus Estimate of $10.7 billion. The year-over-year increase in revenues was dr ...